Warren Hosseinion - Astrana Health CEO, Director
| AMEHDelisted Stock | USD 40.82 0.88 2.11% |
CEO
Dr. Warren Hosseinion, M.D., is the CoChief Executive Officer, Director of Apollo Medical Holdings, Inc. Dr. Hosseinion was our Chief Executive Officer since the inception of the company in July 2008 and our Corporationrationrate Secretary since September 2015. See Proposal 1Election of Directors for additional biographical information about Dr. Hosseinion. . Hosseinion cofounded ApolloMed Hospitalists in Los Angeles with Dr. Adrian Vazquez since 2017.
| Age | 45 |
| Tenure | 7 years |
| Phone | 626 282 0288 |
| Web | https://www.apollomed.net |
Astrana Health Management Efficiency
The company has return on total asset (ROA) of 0.0626 % which means that it generated a profit of $0.0626 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0976 %, meaning that it created $0.0976 on every $100 dollars invested by stockholders. Astrana Health's management efficiency ratios could be used to measure how well Astrana Health manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 229.36 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Astrana Health has a current ratio of 2.44, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Astrana Health until it has trouble settling it off, either with new capital or with free cash flow. So, Astrana Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Astrana Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Astrana to invest in growth at high rates of return. When we think about Astrana Health's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 14 records | CEO Age | ||
| April Anthony | Encompass Health Corp | 53 | |
| Richard Ashworth | Amedisys | 49 | |
| John Rademacher | Option Care Health | 57 | |
| Mark Tarr | Encompass Health Corp | 62 | |
| Theodore CPA | Healthcare Services Group | 50 | |
| Clifford Adlerz | Surgery Partners | 64 | |
| Debra Osteen | Acadia Healthcare | 62 | |
| Patrick Blair | InnovAge Holding Corp | 53 | |
| David Chernow | Select Medical Holdings | 67 | |
| Christopher Christensen | The Ensign Group | 55 | |
| Bassam Damaj | InnovAge Holding Corp | 47 | |
| Paul Kusserow | Amedisys | 63 | |
| Dirk Allison | Addus HomeCare | 68 | |
| Michael Doyle | Surgery Partners | 43 | |
Management Performance
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 |
Astrana Health Leadership Team
Elected by the shareholders, the Astrana Health's board of directors comprises two types of representatives: Astrana Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Astrana. The board's role is to monitor Astrana Health's management team and ensure that shareholders' interests are well served. Astrana Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Astrana Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Li Yu, Director | ||
| WaiChow MD, Chief Officer | ||
| Suresh Nihalani, Independent Director | ||
| Joseph Molina, Director | ||
| Mihir Shah, CFO | ||
| Ernest Bates, Director | ||
| Kenneth Sim, Executive Chairman of the Board | ||
| Linda Marsh, Director | ||
| Thomas Lam, Director | ||
| Carlos MD, Chief Texas | ||
| Hing Ang, COO | ||
| Jeremy MD, Chief Officer | ||
| Brandon Sim, CoChief Officer | ||
| David Schmidt, Independent Director | ||
| Michael Eng, Director | ||
| William Abbott, CFO | ||
| Warren Hosseinion, CEO, Director | ||
| Gary Augusta, Executive Chairman | ||
| John Chiang, Director | ||
| Neil Ahuja, President Solutions | ||
| Edward Schreck, Director | ||
| Mitchell Kitayama, Director | ||
| Kenneth MD, Executive Chairman | ||
| Chandan Basho, CFO Officer | ||
| Albert Young, Co-Chief Medical Officer | ||
| Mark Fawcett, Independent Director | ||
| Yubin Park, Chief Officer | ||
| Dinesh MD, Chief Officer | ||
| John Vong, Chief Officer | ||
| Eric Chin, CFO | ||
| Adrian Vazquez, Chief Medical Officer | ||
| Chan Basho, Chief CFO | ||
| MPH MD, CoCEO President |
Astrana Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Astrana Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0976 | |||
| Return On Asset | 0.0626 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.11 % | |||
| Current Valuation | 1.81 B | |||
| Shares Outstanding | 45.45 M | |||
| Shares Owned By Insiders | 25.77 % | |||
| Shares Owned By Institutions | 46.99 % | |||
| Number Of Shares Shorted | 2.75 M | |||
| Price To Earning | 28.18 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Astrana Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Astrana Health's short interest history, or implied volatility extrapolated from Astrana Health options trading.
Pair Trading with Astrana Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Astrana Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astrana Health will appreciate offsetting losses from the drop in the long position's value.Moving against Astrana Stock
| 0.62 | GFGY | Granite Falls Energy | PairCorr |
| 0.53 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.46 | AMKBF | AP Mller | PairCorr |
| 0.44 | VZ | Verizon Communications Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Astrana Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Astrana Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Astrana Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Astrana Health to buy it.
The correlation of Astrana Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Astrana Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Astrana Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Astrana Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Astrana Health information on this page should be used as a complementary analysis to other Astrana Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Astrana Stock
If you are still planning to invest in Astrana Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Astrana Health's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |